- Home
- ALHC vs KYMR Comparison
ALHC vs KYMR Comparison
Compare ALHC & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALHC
- KYMR
- Stock Information
- Founded
- ALHC 2013
- KYMR 2015
- Country
- ALHC United States
- KYMR United States
- Employees
- ALHC N/A
- KYMR N/A
- Industry
- ALHC Medical Specialities
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- ALHC Health Care
- KYMR Health Care
- Exchange
- ALHC Nasdaq
- KYMR Nasdaq
- Market Cap
- ALHC 2.9B
- KYMR 3.1B
- IPO Year
- ALHC 2021
- KYMR 2020
- Fundamental
- Price
- ALHC $12.97
- KYMR $42.96
- Analyst Decision
- ALHC Buy
- KYMR Strong Buy
- Analyst Count
- ALHC 11
- KYMR 16
- Target Price
- ALHC $17.85
- KYMR $58.94
- AVG Volume (30 Days)
- ALHC 3.8M
- KYMR 557.2K
- Earning Date
- ALHC 07-30-2025
- KYMR 08-11-2025
- Dividend Yield
- ALHC N/A
- KYMR N/A
- EPS Growth
- ALHC N/A
- KYMR N/A
- EPS
- ALHC N/A
- KYMR N/A
- Revenue
- ALHC $3,335,894,000.00
- KYMR $58,885,000.00
- Revenue This Year
- ALHC $43.40
- KYMR $58.26
- Revenue Next Year
- ALHC $25.87
- KYMR N/A
- P/E Ratio
- ALHC N/A
- KYMR N/A
- Revenue Growth
- ALHC 49.46
- KYMR N/A
- 52 Week Low
- ALHC $7.92
- KYMR $19.45
- 52 Week High
- ALHC $21.06
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- ALHC 48.38
- KYMR 42.21
- Support Level
- ALHC $11.66
- KYMR $43.21
- Resistance Level
- ALHC $16.24
- KYMR $44.94
- Average True Range (ATR)
- ALHC 0.78
- KYMR 1.43
- MACD
- ALHC 0.14
- KYMR -0.47
- Stochastic Oscillator
- ALHC 29.14
- KYMR 5.86
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.